Feb 28, 2024 / 02:10PM GMT
Stephen V. Byrne - BofA Securities, Research Division - MD of America Equity Research & Research Analyst
I want to get going on this one with Corteva. We have so much to talk about. But I want to make sure you know who's up here with me: Dave Anderson, CFO of Corteva; and Chuck Magro, CEO. Chuck has been in this conference for many, many years. He was previously representing Nutrien at one time. He was representing Agrium before that. So -- but he's got a wealth of experience, and he's been in my world for a long time, there's NOVA Chemicals before that.
A lot of moving parts in agriculture that are affecting Corteva. So we've got a lot of things to talk about. I got way more than 30 minutes of questions here. But if you want to jump in later, for sure, we'll give you that opportunity.
Questions and Answers:
Stephen V. Byrne - BofA Securities, Research Division - MD of America Equity Research & Research AnalystMaybe to start things off here, Chuck, maybe some high-level comments about where you see 2024 going for Corteva.
Trustpilot
